Showing 8071 - 8080 of 8146 for "Patent litigation" with applied filters
01 September 2018 by ABE & Partners
The Japanese IP system has vulnerable evidence collection procedures in comparison with foreign countries.
01 September 2018 by Managing Intellectual Property
Early this year, the Mexican Institute of Industrial Property issued decisions denying registration for the trade mark PINCHE GRINGO BBQ & Design in classes 43 (restaurants) and 30 (sauces)
01 September 2018 by Thomas Gibb
In recent years, machine learning and so-called ‘artificial intelligence’ systems have once again come into the spotlight.
01 September 2018 by Norton Rose Fulbright
Big names in Hollywood, sports, and music often enforce their personality rights
01 September 2018 by FB Rice
It is a long-standing principle of Australian patent law that determining whether or not a patent application is directed towards patentable subject matter should be done separately to determining issues of novelty and inventive step.
01 September 2018 by Jakob Pade Frederiksen
Pursuant to Rule 71(3) of the European Patent Convention (EPC), towards the termination of the examination proceedings, the Examining Division of the European Patent Office (EPO) shall inform the applicant of the text in which it intends to grant the European patent.
01 September 2018 by Managing Intellectual Property
In Taiwan, both invention and design applications are subject to substantive examination.
01 September 2018 by Spoor & Fisher
On June 28 2018 the Zimbabwean authorities published a document entitled the Zimbabwe Intellectual Property Policy and Implementation Strategy.
01 September 2018 by Jing He
On June 1 2018, the Supreme People’s Court of China (SPC) issued the draft judicial interpretation on patent validity and examination cases for public comments
01 September 2018 by Managing Intellectual Property
Resolution Chemicals v AstraZeneca B.V. and Shionogi (Supreme Court of The Netherlands, The Hague, June 8 2018) deals with the extent of the protection that is conferred by patent EP0521471 (EP 471), for rosuvastatin, a new cholesterol inhibitor.